SB 6593: Rx drug prices
Promoting greater fairness for taxpayers in prescription drug costs by pursuing prices that are aligned with or lower than the negotiated prices available to the United States veterans administration.
Summary
- State agencies that enter into an agreement with a drug manufacturer, distributor, or pharmacy benefit manager must ensure that the purchase price of the drug reflects all available rebates, cash discounts, volume discounts, donations, and other discounts or credits available to the agency.
From the Senate Bill Report (Orig.) (SB 6593), written by the Legislature's nonpartisan staff. Read the full report ↗
- IntroducedJan 28, 2016
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Senator (D-36)
- Introduced
- January 28, 2016 in the Senate
- Last action
- March 10, 2016
- Budget
- Has a fiscal note
AN ACT Relating to promoting greater fairness for taxpayers in prescription drug costs by pursuing prices that are aligned with or lower than the negotiated prices available to the United States veterans administration;
Sponsors
Prime sponsor: Senator (D-36)
5 co-sponsors (3 Democrats, 2 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care.
SB 6593 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6593 (2019–20) Doulas, health profession
- SB 6593 (2017–18) Evergreen promise program
- SB 6593 (2011–12) Epinephrine auto-injectors
- SB 6593 (2009–10) Infant & toddler program
- SB 6593 (2007–08) Groundwater monitoring
- SB 6593 (2005–06) Uniform securities
- SB 6593 (2003–04) Discrimination in housing
- SB 6593 (2001–02) Rev reductions/local gvrnmnt